Medication use in the treatment of migraine during pregnancy and lactation

被引:24
作者
Lucas, Sylvia
机构
[1] The Headache Center, University of Washington Medical Center, Seattle, WA 98195
关键词
1ST TRIMESTER EXPOSURE; SUMATRIPTAN; DRUGS; PREDICTION; EXCRETION; SAFETY;
D O I
10.1007/s11916-009-0064-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Migraine is very common in women of reproductive age. With peak prevalence of migraine occurring during childbearing years, many women with migraine may knowingly or unknowingly use medication during pregnancy. Although migraine tends to improve during pregnancy, many women may still experience moderate to severe disabling headache and need pharmacologic treatment for the pain, nausea, and vomiting. This article explores the physiologic changes occurring during pregnancy that can affect pharmacokinetic properties of drugs and their metabolism. Acute and preventive treatment of migraine during pregnancy and lactation is discussed, with an emphasis on safety to the fetus and nursing infant. Safety and recommended use of medication during pregnancy may be different when use is considered during breastfeeding. A goal of treatment is to balance potential risk of treatment to the fetus and nursing infant with significant relief and return to normal function of the mother.
引用
收藏
页码:392 / 398
页数:7
相关论文
共 38 条
[1]  
*AM AC PED, AM AC PED POL STAT
[2]  
American Academy of Pediatrics Committee on Drugs, 2001, Pediatrics, V108, P776
[3]   Using pharmacokinetics to predict the effects of pregnancy and maternal-infant transfer of drugs during lactation [J].
Anderson, Gail D. .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (06) :947-960
[4]   PREDICTION OF DRUG DISTRIBUTION INTO HUMAN-MILK FROM PHYSICOCHEMICAL CHARACTERISTICS [J].
ATKINSON, HC ;
BEGG, EJ .
CLINICAL PHARMACOKINETICS, 1990, 18 (02) :151-167
[5]  
Begg Evan J, 2002, J Hum Lact, V18, P323, DOI 10.1177/089033402237904
[6]  
Boothby LA, 2001, ANN PHARMACOTHER, V35, P1485
[7]   Comparison of three outpatient regimens in the management of nausea and vomiting in pregnancy [J].
Fadi A Bsat ;
Despina E Hoffman ;
David E Seubert .
Journal of Perinatology, 2003, 23 (7) :531-535
[8]   The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study [J].
Einarson, A ;
Maltepe, C ;
Navioz, Y ;
Kennedy, D ;
Tan, MP ;
Koren, G .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2004, 111 (09) :940-943
[9]   Use of 5-HT1 agonists in pregnancy [J].
Evans, Emily W. ;
Lorber, Kristin C. .
ANNALS OF PHARMACOTHERAPY, 2008, 42 (04) :543-549
[10]  
*GLAXOSMITHKLINE, 1996, SUM NAR PREG REG INT